STRYKER WKN: 864952 ISIN: US8636671013 Kürzel: SYK Forum: Aktien Thema: Hauptdiskussion

$SYK | Stryker Q2'24 Earnings Highlights: 🔹 Adjusted EPS: $2.81 (Est. $2.79) 🟢 🔹 Net Sales: $5.42B (Est. $5.41B) 🟢; UP +8.5% YoY FY'24 Forecast: 🔹 Adj EPS: $11.90 to $12.10 (Prev. $11.85 to $12.05; Est. $11.95) 🟡 🔹 Organic Revenue Growth: +9% to +10% (Prev. +8.5% to +9.5%) Segment Performance: MedSurg & Neurotechnology: 🔹 Net Sales: $3.12B (Est. $3.12B) 🟡 🔹 Instruments Net Sales: $698M (Est. $697.4M) 🟡 🔹 Endoscopy Net Sales: $768M (Est. $775.2M) 🔴 🔹 Medical Sales (including intersegment): $908M (Est. $909.1M) 🟡 🔹 Neurovascular Net Sales: $327M (Est. $334.4M) 🔴 🔹 Neuro Cranial Net Sales: $416M (Est. $402.5M) 🟢 Orthopaedics & Spine: 🔹 Net Sales: $2.31B (Est. $2.28B) 🟢 🔹 Knees Net Sales: $602M (Est. $600.5M) 🟡 🔹 Hips Net Sales: $428M (Est. $413.8M) 🟢 🔹 Trauma and Extremities Net Sales: $832M (Est. $825M) 🟡 🔹 Spine Net Sales: $307M (Est. $309.2M) 🔴 🔹 Other Orthopaedics & Spine Net Sales: $136M (Est. $128.5M) 🟢 Key Financial Metrics: 🔹 Adjusted Gross Profit Margin: 64.2% (Est. 64.1%) 🟡 🔹 Adjusted Operating Margin: 24.6% (Est. 24.4%) 🟡 CEO Kevin A. Lobo's Commentary: 🔸 "We delivered another quarter of strong organic sales growth. We remain committed to our margin expansion goals and are excited about our product and M&A pipelines." Company Highlights: 🔸 The company noted that foreign exchange rates could have a moderately unfavorable impact on full-year net sales, with an expected negative impact on adjusted net earnings per diluted share in the range of $0.10 to $0.15.

https://www.prnewswire.com/news-releases/strykers-spine-guidance-5-software-featuring-copilot-receives-510k-clearance-from-fda-302209090.html Stryker's Spine Guidance 5 Software featuring Copilot receives 510(k) clearance from FDA Q Guidance System with Spine Guidance 5 Software featuring Copilot is a first-to-market technology, pioneering new planning and surgical capabilities

Heute kommen zahlen

Letztes mal hat sich nach den Zahlen nichts getan,obwohl die gut waren

Ja

Zahlen kommen Dienstag.

Jemand was von schlechten Zahlen gehört?

Hat wohl auch mit den Wahlen in Amerika zu tun

.ich glaube selbst nach Guten zahlen wird nicht steigen

Und wieder alles auf Null

Zahlen sind gut ,aber aktie soll schon. Vorweggenommen haben..die war bei 335 Euro.. hätte ich verkaufen sollen

200 Tage Linie ca. bei 320$

Zahlen sollen sehr gut werden

Keine Ahnung..zahlen kommen bald ..Bin gespannt

Warum der Dip heute?

Zahlen übertroffen, aktie fällt trotzdem